Stay updated on Pembrolizumab in Advanced Adrenocortical Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Adrenocortical Carcinoma Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Adrenocortical Carcinoma Clinical Trial page
- Check5 days agoChange DetectedThe page’s revision/version indicator was updated from **v3.5.2** to **v3.5.3**, reflecting a change in the site’s interface or backend version rather than the underlying clinical trial information.SummaryDifference0.1%

- Check12 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check20 days agoChange DetectedUpdates to the Study Record Dates (e.g., 2026-04-06; 2026-03-23) reflect maintenance of the page's history. The core trial information remains unchanged.SummaryDifference0.3%

- Check27 days agoChange DetectedAdded Adrenal cortex carcinoma as a visible keyword/context reference and linked a Genetics and Rare Diseases Information Center resource. This provides additional background context and a direct external reference related to the study topic.SummaryDifference0.2%

- Check41 days agoChange DetectedPage revision updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.1%

- Check48 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3. No visible changes to study information or page layout.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Advanced Adrenocortical Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Adrenocortical Carcinoma Clinical Trial page.